We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.36B
AUM Growth
+$457M
Cap. Flow
-$178M
Cap. Flow %
-2.42%
Top 10 Hldgs %
26.1%
Holding
2,906
New
66
Increased
422
Reduced
1,573
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 25.69%
2 Consumer Discretionary 12.47%
3 Healthcare 12.1%
4 Financials 11.43%
5 Communication Services 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CERS icon
1901
Cerus
CERS
$572M
$240K ﹤0.01%
35,217
-12,028
-25% -$81K
RC
1902
Ready Capital
RC
$289M
$239K ﹤0.01%
15,318
+582
+4% +$9.07K
KROS icon
1903
Keros Therapeutics
KROS
$222M
$239K ﹤0.01%
4,082
GRBK icon
1904
Green Brick Partners
GRBK
$3.02B
$239K ﹤0.01%
7,873
SCS
1905
DELISTED
Steelcase
SCS
$238K ﹤0.01%
20,327
-1,265
-6% -$15.2K
GES
1906
DELISTED
Guess Inc
GES
$238K ﹤0.01%
10,053
RCKT icon
1907
Rocket Pharmaceuticals
RCKT
$367M
$238K ﹤0.01%
10,885
EQH icon
1908
Equitable Holdings
EQH
$14.1B
$237K ﹤0.01%
7,229
-115
-2% -$3.77K
NAPA
1909
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$237K ﹤0.01%
10,140
+3,195
+46% +$66.5K
AYX
1910
DELISTED
Alteryx Inc
AYX
$237K ﹤0.01%
3,910
-31
-0.8% -$2.14K
GOEV
1911
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$237K ﹤0.01%
67
INO icon
1912
Inovio Pharmaceuticals
INO
$93M
$236K ﹤0.01%
3,946
-13
-0.3% -$1.04K
STNE icon
1913
StoneCo
STNE
$2.49B
$236K ﹤0.01%
14,002
-106
-0.8% -$2.69K
AZEK
1914
DELISTED
The AZEK Co
AZEK
$236K ﹤0.01%
5,101
-29
-0.6% -$1.15K
VIVO
1915
DELISTED
Meridian Bioscience Inc
VIVO
$236K ﹤0.01%
11,562
-2,403
-17% -$46.1K
PLOW icon
1916
Douglas Dynamics
PLOW
$981M
$236K ﹤0.01%
6,032
AMPH icon
1917
Amphastar Pharmaceuticals
AMPH
$858M
$236K ﹤0.01%
10,115
-2,428
-19% -$49.6K
IMAX icon
1918
IMAX
IMAX
$2.81B
$235K ﹤0.01%
13,164
+1,537
+13% +$29.5K
BFLY icon
1919
Butterfly Network
BFLY
$2.36B
$235K ﹤0.01%
35,065
-14,091
-29% -$124K
AWI icon
1920
Armstrong World Industries
AWI
$7.75B
$234K ﹤0.01%
2,017
-10
-0.5% -$1.08K
AAN
1921
DELISTED
The Aaron's Company Inc
AAN
$234K ﹤0.01%
9,494
ARCT icon
1922
Arcturus Therapeutics
ARCT
$223M
$233K ﹤0.01%
6,309
VNDA icon
1923
Vanda Pharmaceuticals
VNDA
$314M
$232K ﹤0.01%
14,805
+1,386
+10% +$24.2K
BJRI icon
1924
BJ's Restaurants
BJRI
$1.48B
$231K ﹤0.01%
6,694
WINA icon
1925
Winmark
WINA
$1.26B
$231K ﹤0.01%
931

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 Portfolio in Review

As of Q4 2021, Metropolitan Life Insurance Company (MetLife) held 2,906 positions worth $7.36B, up 6.6% from $6.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 filing shows 66 new, 422 increased, 1,573 reduced and 124 closed positions. Its largest new stake was Kyndryl: 32,951 shares worth $596K. The largest sale was iShares Russell 1000 Growth ETF, an estimated $18.3M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2021 buy was Kyndryl: 32,951 shares worth $596K.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $34.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $18.3M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Kansas City Southern in Q4 2021, selling an estimated $3.18M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 26% of its $7.36B portfolio in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 66 new positions and closed 124 in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.6% quarter-over-quarter to $7.36B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.